Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-06 OYLER JOHN Chief Executive Officer Sale −7,701 $196.62 $1.5M 8,861
2020-07-06 OYLER JOHN Chief Executive Officer Sale −6,300 $197.43 $1.2M 2,561
2020-07-06 OYLER JOHN Chief Executive Officer Sale −2,561 $198.32 $508K 0
2020-07-01 Wang Xiaodong Director Sale −690 $189.19 $131K 4,157
2020-07-01 Wang Xiaodong Director Sale −2,100 $190.46 $400K 2,057
2020-07-01 Wang Xiaodong Director Sale −1,600 $191.37 $306K 457
2020-07-01 Wang Xiaodong Director Sale −457 $192.31 $88K 0
2020-07-01 OYLER JOHN Chief Executive Officer Sale −2,016 $191.10 $385K 1,800
2020-07-01 OYLER JOHN Chief Executive Officer Sale −1,800 $192.08 $346K 0
2020-06-29 OYLER JOHN Chief Executive Officer Sale −300 $191.56 $57K 1,135
2020-06-29 OYLER JOHN Chief Executive Officer Sale −1,100 $192.84 $212K 35
2020-06-29 OYLER JOHN Chief Executive Officer Sale −35 $193.68 $7K 0
2020-06-29 Liang Howard CFO & Chief Strategy Officer Sale −300 $191.23 $57K 0
2020-06-29 Huang Jane CMO, Hematology Sale −435 $192.46 $84K 0
2020-06-29 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-06-29 Huang Jane CMO, Hematology Sale −300 $187.91 $56K 1,200
2020-06-29 Huang Jane CMO, Hematology Sale −402 $188.95 $76K 798
2020-06-29 Huang Jane CMO, Hematology Sale −500 $191.37 $96K 298
2020-06-29 Huang Jane CMO, Hematology Sale −198 $192.72 $38K 100
2020-06-29 Huang Jane CMO, Hematology Sale −100 $193.56 $19K 0

Page 91 of 99 · 1,972 trades